death domain receptor

• デスドメイン受容体、デスドメインレセプター

関

death receptor

WordNet

1. the time when something ends; "it was the death of all his plans"; "a dying of old hopes" (同)dying, demise
2. the time at which life ends; continuing until dead; "she stayed until his death"; "a struggle to the last" (同)last
3. the absence of life or state of being dead; "he seemed more content in death than he had ever been in life"
4. the permanent end of all life functions in an organism or part of an organism; "the animal died a painful death"
5. the act of killing; "he had two deaths on his conscience"
6. the event of dying or departure from life; "her death came as a terrible shock"; "upon your decease the capital will pass to your grandchildren" (同)decease, expiry
7. territory over which rule or control is exercised; "his domain extended into Europe"; "he made it the law of the land" (同)demesne, land
8. (mathematics) the set of values of the independent variable for which a function is defined (同)domain of a function
9. a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response
10. the personification of death; "Death walked the streets of the plague-bound city"

PrepTutorEJDIC

1. 〈U〉〈C〉『死』,死亡;死に方,死にざま / 〈U〉死んだ[ような]状体 / 《the~》(…の)絶滅,破滅《+『of』+『名』》 / 《the~》(…の)死の原因,命取り《+『of』+『名』》 / 《通例『D-』》死神(手に鎌(かマ)を持った黒装束の骸骨(がいこつ)で表される)
2. (国の)領地,領土;(個人の)所有地 / (関心・活動などの)範囲,分野 / (個人・一族の)所有地 / (数学で)変域(関数の独立変数がとる値の集合)
3. =sense organ / 受信装置

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 進行非小細胞肺癌に対する遺伝子型による個別治療 personalized genotype directed therapy for advanced non small cell lung cancer
• 2. 肝線維症の病因 pathogenesis of hepatic fibrosis
• 3. SIDSを含む乳児の予期せぬ死亡：初期マネージメント sudden unexpected infant death including sids initial management
• 4. 乳幼児突然死症候群：危険因子およびリスク低減戦略 sudden infant death syndrome risk factors and risk reduction strategies
• 5. 死産の評価 evaluation of stillbirth

English Journal

• Differentiating mTOR inhibitors in renal cell carcinoma.

• Pal SK, Quinn DI.SourceDepartment of Medical Oncology & Experimental Therapeutics, Division of Genitourinary Malignancies, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: SPal@coh.org.
• Cancer treatment reviews.Cancer Treat Rev.2013 Nov;39(7):709-19. doi: 10.1016/j.ctrv.2012.12.015. Epub 2013 Feb 21.
• PI3K/Akt/mTOR signalling is dysregulated in many cancers, including renal cell carcinoma (RCC), and activation of this pathway has been suggested to correlate with aggressive behavior and poor prognosis in RCC tumors. mTOR inhibition plays a principal role in the targeted treatment of many cancer ty
• PMID 23433636

• Macrophages engulfing apoptotic thymocytes produce retinoids to promote selection, differentiation, removal and replacement of double positive thymocytes.

• Sarang Z, Garabuczi E, Joós G, Kiss B, Tóth K, Rühl R, Szondy Z.SourceSection of Dental Biochemistry, Department of Biochemistry and Molecular Biology, Research Center of Molecular Medicine, University of Debrecen, Nagyerdei krt. 98, 4012 Debrecen, Hungary.
• Immunobiology.Immunobiology.2013 Nov;218(11):1354-60. doi: 10.1016/j.imbio.2013.06.009. Epub 2013 Jul 19.
• The thymus provides the microenvironment in which thymocytes develop into mature T-cells, and interactions with thymic stromal cells are thought to provide the necessary signals for thymocyte maturation. Recognition of self-MHC by T-cells is a basic requirement for mature T-cell functions, and those
• PMID 23932496

• Antagonistic functional duality of cancer genes.

• Stepanenko AA, Vassetzky YS, Kavsan VM.SourceState Key Laboratory of Molecular and Cellular Biology, Institute of Molecular Biology and Genetics, 150 Zabolotnogo Street, Kyiv 03680, Ukraine. Electronic address: a.a.stepanenko@gmail.com.
• Gene.Gene.2013 Oct 25;529(2):199-207. doi: 10.1016/j.gene.2013.07.047. Epub 2013 Aug 9.
• Cancer evolution is a stochastic process both at the genome and gene levels. Most of tumors contain multiple genetic subclones, evolving in either succession or in parallel, either in a linear or branching manner, with heterogeneous genome and gene alterations, extensively rewired signaling networks
• PMID 23933273

Japanese Journal

• TNF Receptor-Associated Factor (TRAF) Signaling Network in CD4⁺ T-Lymphocytes

• The Tohoku Journal of Experimental Medicine 236(2), 139-154, 2015
• NAID 130005075699

• Inhibition of RAGE signaling through the intracellular delivery of inhibitor peptides by PEI cationization

• International Journal of Molecular Medicine 32(4), 938-944, 2013-10
• NAID 120005425664

• 敗血症の転帰に影響を与える遺伝子多型

• 日本救急医学会雑誌 24(1), 1-11, 2013
• NAID 130004840941

Related Links

• Death Receptor Signaling - Journal of Cell Science

Death receptor signaling Inna Lavrik, Alexander Golks, Peter H. Krammer Division of Immunogenetics, Tumorimmunology Program, German Cancer Research Center (DKFZ), INF 280, 69120 Heidelberg, Germany Journal of Cell ...

• Death Receptor Signalling - University of Reading

... is slightly simpler than through the TNF receptor. The adapter protein FADD can be recruited directly to the death domain on the Fas receptor, without requiring the prior recruitment of TRADD. In addition the Fas receptor In a ...

---

★リンクテーブル★

リンク元	「デスドメイン受容体」「death receptor」「デスドメインレセプター」
拡張検索	「death domain receptor signaling adaptor protein」
関連記事	「domain」「death」「domains」

「デスドメイン受容体」

　　[★]

英

death domain receptor

関

細胞死受容体、デスドメインレセプター

「death receptor」

　　[★]

• 細胞死受容体、デスレセプター

関

death domain receptor、DR

「デスドメインレセプター」

　　[★]

英

death domain receptor

関

デスドメイン受容体

「death domain receptor signaling adaptor protein」

　　[★]

• デスドメイン受容体シグナルアダプタータンパク質

「domain」

　　[★]

• n.

• ドメイン、(分子内の)領域、分域

関

area、realm、region、regional、segregation、territory、universe

　 　 　

「death」

　　[★]

• n.

• 死

　 　 　 　 　 　 　

「domains」

　　[★]

関

See also specific type